Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge

NCT03223584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-02-13

No results posted yet for this study

Summary

Title of the research:

Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge

Study area:

Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group).

Aims:

From an explorative angle, the study aims to identify hurdles, barriers, facilitators and needs that general practitioners and community pharmacists experience with patients who have recently been discharged from a hospital. From a feasibility standpoint, the study aims to investigate what supportive actions are feasible and useful to optimize the care process upon hospital discharge. For this purpose, a discharge document for the community pharmacist will be shown to the healthcare professionals. The HCP will be given the opportunity to give feedback on this document.

Study design:

A non-interventional, qualitative study is set up using face-to-face, semi-structured interviews and a focus group.

Study population:

Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.

Number of health care professionals:

Individual interviews will be organised until there is saturation of information and no new elements are provided in the interviews. At least five community pharmacists and five general practitioners will be interviewed per care region. In addition, a focus group will take place in care region Mortsel.

Procedures:

Upon an informed consent of the healthcare professional, a semi-structured face-to-face interview will take place. The interview will focus on concrete patient cases, provided by the healthcare professional, as well as a fictional case of the researcher. In the focus group, data of the individual interviews will be presented and the relevance and completeness of the information will be assessed. Finally, the aim of the focus group is to reach a consensus on the research questions.

Conditions

  • Pharmacist
  • Physicians, Primary Care
  • Patient Discharge

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03223584 on ClinicalTrials.gov